Making It Stick: Considerations & Case Studies for Implementation of Long-Acting Antiretroviral Therapy
|
Release Date: December 18, 2025 |
 |
Support for this activity has been made possible through educational grants from Gilead Sciences and Merck. |
- There are no fees to participate in the activity.
- Participants must view the activity description, including disclosures, and watch the video.
- At the conclusion of the program, go to: https://form.jotform.com/AcademyCME/2AC25W4LA
- Your certificate will be emailed to you within 24 hours
- If you have any questions, please contact [email protected] for assistance.
Resources
-
Cabenuva® Prescribing Information: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212888
-
Apretude® Prescribing Information: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215499
-
Sunlenca® Prescribing Information: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215973
-
Yeztugo® Prescribing Information: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220018
-
Trogarzo® Prescribing Information: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process
-
DHS Guidelines: https://clinicalinfo.hiv.gov/en/guidelines
-
National HIV Curriculum: https://hiv.uw.edu
-
National Clinician Consultation Center: https://nccc.ucsf.edu
-
AAHIVM Long-Acting Agent Resource Center: https://hivlaa.org
-
Liverpool Drug Interaction Checker: https://hiv-druginteractions.org
-
AIDS Education & Training Centers: https://aidsetc.org
-
ACTHIV® Resources for the Care Team: https://acthiv.org/wp-content/uploads/2025/05/ACTHIV-Resources-for-HIV-Team-updated-03-21-25.pdf